Hantavirus Outbreak: Third UK Case Suspected as WHO Rules Out Pandemic

Hantavirus Outbreak Aboard MV Hondius: What You Need to Know

A rare and deadly hantavirus outbreak aboard a cruise ship has triggered an international public health response. The outbreak, centered on the Dutch-flagged vessel MV Hondius, has resulted in several severe illnesses and multiple deaths, prompting the World Health Organization (WHO) to issue a risk assessment and clarify the nature of the virus to prevent global alarm.

While the situation is serious for those on board, health officials are emphasizing that this event does not pose a significant threat to the general global population. Here is a comprehensive look at the current situation, the science behind the virus, and the official risk assessment.

The Current Situation: MV Hondius Outbreak

The outbreak was first reported to the WHO on May 2, 2026, following notifications from the United Kingdom. The MV Hondius was traveling from Argentina to Cabo Verde with a total of 147 passengers and crew members.

As of May 7, 2026, the United Nations reports that eight cases have been identified. This includes five laboratory-confirmed infections and three suspected cases. The outbreak has been fatal for three individuals, while others have faced critical illness requiring intensive care.

The illness onset occurred between April 6 and April 28, 2026. Patients presented with a rapid progression of symptoms, starting with fever and gastrointestinal issues, which quickly evolved into pneumonia, shock, and acute respiratory distress syndrome.

Understanding the Andes Strain of Hantavirus

Hantaviruses are zoonotic, meaning they are primarily transmitted from animals to humans. Most hantaviruses are spread through contact with the urine, saliva, or droppings of infected rodents. However, the outbreak on the MV Hondius is linked to the Andes strain, which possesses a unique and concerning characteristic.

The Andes virus, found primarily in parts of Latin America, is the only known hantavirus capable of limited human-to-human transmission. According to the World Health Organization, this type of transmission generally requires close and prolonged contact, such as that found between intimate partners, household members, or healthcare workers.

Symptoms and Clinical Progression

Hantavirus Pulmonary Syndrome (HPS) is a severe respiratory disease. The progression typically follows a distinct pattern:

• Early Stage: Patients often experience flu-like symptoms, including fever, fatigue, and muscle aches (particularly in the thighs, hips, and back). Gastrointestinal issues, such as nausea and vomiting, are also common.
• Late Stage: Four to 10 days after the initial symptoms, the disease progresses to the lungs. This is characterized by coughing, shortness of breath, and the filling of the lungs with fluid, leading to acute respiratory distress.

Global Risk Assessment: “Not Another COVID”

Given the history of global pandemics, the WHO has been proactive in framing the risk level of this outbreak. WHO Director-General Tedros Adhanom Ghebreyesus stated that the overall public health risk remains low.

Maria Van Kerkhove, the WHO acting director for epidemic and pandemic management, explicitly distinguished this event from the 2020 coronavirus pandemic. “This is not SARS-CoV-2. This is not the start of a COVID pandemic,” Van Kerkhove stated, noting that hantaviruses are well-known to the medical community and do not behave like the virus that caused COVID-19.

Key Takeaways

Looking Forward

The international response currently involves coordinated efforts across Europe, Africa, and Latin America. Management strategies include case isolation, medical evacuations, and rigorous laboratory investigations to determine the exact source of the infection on the vessel. While the limited human-to-human transmission of the Andes strain requires vigilance, the lack of widespread community transmission suggests that the outbreak will remain contained.